% | $
Quotes you view appear here for quick access.

Radware Ltd. (RDWR) Message Board

acowoman 4 posts  |  Last Activity: Jul 29, 2015 2:35 PM Member since: Jan 25, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Another view of Investor/Analyst Day

    by sbh3117 Jun 9, 2015 12:39 PM
    acowoman acowoman Jun 23, 2015 3:24 PM Flag

    sbh, nice find, I am not expecting anything said but on June 25, Bayer is holding an analyst meeting in New York. It would be nice if they said something about their preclinical pipeline. Also we will be speaking at German/Israel innovation day. Makes sense considering Bayer and German Merck. Other health care speaker is Teva.

  • Reply to

    the life sciences report

    by suejenseth Jun 25, 2015 9:29 AM
    acowoman acowoman Jun 25, 2015 9:43 AM Flag

    Another thing happen to notice that Martin will be presenting at the Money Show in San Francisco this year. Interesting venue.

  • Reply to

    Brah re: Anat

    by bauersteven12 Jun 25, 2015 2:43 PM
    acowoman acowoman Jun 26, 2015 12:46 PM Flag

    Banana, I did hear her make the statement you refer to, I believe it was that it was not one of CGENs objectives for the year. I was not close enough to see if Martin's eyes rolled back. I asked about 15001. The impression the answer gave me is that they are looking for a partner there is nothing more Cgen plans to do with it. So I figured though we may not choose to get a deal on an immune oncology product we "should" do something on 15001this year. The question that I was disappointed that I did not ask nor did anyone else was how Bayer was going. It was mentioned several times by several presenters that the Bayer partnership was moving along. But I would have liked something more then that. Yesterday Bayer had their big analyst meeting, I looked at the slides and it does not look like preclinicals were discussed. May account for some of todays softness, hard to tell as volumes pretty weak.
    Getting back to her as a CEO, more important then even Gerstell, is our stellar scientific committee. Pardoll and Drake will be opening the doors we need. Anat appears to be a superior scientist who based on absolutely no knowledge on my part seems to have the respect of her staff and we hope has made some excellent decisions. For the current size of the company she is fine. Though communications are not her strong suit.
    I too am disappointed that we have not attracted the investment community to our cause. Success will change that.
    looks like another buying opportunity coming.

  • Reply to

    Anything under $22.00 is a steal

    by malakacrocka Jun 9, 2015 10:52 PM
    acowoman acowoman Jul 29, 2015 2:35 PM Flag

    Bought some today, frankly I don't quite get it. as long as we stay in business 9+ per cent pretty good. Fed would have to hike quite a bit which would mean business is good. I always feel I amnot he smartest person on the block so don't quite know why am being so lucky to get this at this price.

17.80-0.23(-1.28%)Sep 4 3:59 PMEDT